Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Leukotriene E4 receptor is a putative cell-surface receptor hypothesized to specifically bind and mediate the biological effects of leukotriene E4 (LTE4). While classical CysLT1R and CysLT2R receptors bind LTE4 weakly, evidence suggests the existence of additional distinct receptor(s) with high selectivity for LTE4, such as P2Y12 or a functionally observed receptor in mouse skin ("CysLTR_ER"). Activation of this putative receptor leads to bronchoconstriction, airway hyperresponsiveness, and inflammatory cell influx, particularly relevant in asthma and other allergic/inflammatory conditions. Its precise molecular identity remains under investigation.
Currently unknown, but hypothesized to involve G protein activation and downstream signaling pathways, or direct interaction with P2Y12 related pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leukotriene E4 Receptor (LTE4 Receptor).